Skip to main content

Table 4 Multi-dimensionality reduction models for apoptosis-related markers in relation to aggressive prostate cancer (PCA)

From: Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer

Best Model

Cross Validation

Consistency (CVC)*

Average Testing

Accuracy (ATA)*

Permutation Testing

p value*

One Factor

AKT3 rs2125230

9/10

0.512

0.282

Two Factor

AKT3 rs2125230

PRKCQ rs571715

9/10

0.563

0.011

Three Factor

AKT3 rs2125230

BID rs366542

PRKCQ rs571715

6/10

0.529

0.127

Four Factor

AKT3 rs2125230

BCL2L14 rs2448050

BID rs366542

TNFRSF1A rs4149576

2/10

0.517

0.321

  1. *Adjusted for age and family history of prostate cancer (PCA)